Clinical Trials Directory

Trials / Completed

CompletedNCT01351818

Adipocyte Function and Somtropin Deficiency

The Fayds Project: Adipocyte Function and Somtropin Deficiency

Status
Completed
Phase
Study type
Observational
Enrollment
62 (actual)
Sponsor
Ferring Pharmaceuticals · Industry
Sex
All
Age
5 Years – 12 Years
Healthy volunteers
Not accepted

Summary

To assess the influence of exogenous GH (growth hormone) administration on adipocyte endocrine function (leptin, adiponectin, and resistin) and on ghrelin secretion in children with delayed growth due to GH deficiency. Study hypothesis: hormones produced by the adipocyte (leptin, adiponectin, and resistin) and ghrelin may exert a certain control on production of GH and IGF-I, and GH may in turn have a regulatory effect on such hormones.

Conditions

Interventions

TypeNameDescription
DRUGGrowth Hormone

Timeline

Start date
2005-05-01
Primary completion
2008-01-01
Completion
2008-03-01
First posted
2011-05-11
Last updated
2011-05-11

Locations

12 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT01351818. Inclusion in this directory is not an endorsement.